GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS INCREASE SOLID GASTRIC RESIDUE RATES ON UPPER ENDOSCOPY ESPECIALLY IN COMPLICATED DIABETIC PATIENTS: A CASE CONTROL STUDY.
Kevin GarzaEli AminpourJanaki ShahBhati MehtaDayna EarlyChandra Prakash GyawaliVladimir KushnirPublished in: The American journal of gastroenterology (2024)
GLP-1RA use is associated with increased gastric residue on upper endoscopy, particularly in T2DM patients, surpassing the impact of opiates alone. Risk is highest in the presence of T2DM complications, while prolonged fasting and a clear-liquid diet are protective. This increased risk of gastric residue does not appear to translate to an increased risk of procedural complications.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- risk factors
- rheumatoid arthritis
- chronic kidney disease
- prognostic factors
- physical activity
- small bowel
- amino acid
- type diabetes
- insulin resistance
- blood glucose
- weight loss
- adipose tissue
- ionic liquid
- skeletal muscle
- metabolic syndrome
- ankylosing spondylitis
- disease activity
- systemic sclerosis